An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia

被引:3
|
作者
Li, Xue-Ying [1 ,2 ,3 ]
Qian, Jie-Jing [1 ,2 ,3 ]
Yang, Min [1 ,2 ,3 ]
Zhang, Yi [1 ,2 ,3 ]
Wang, Sha-Sha [1 ,2 ,3 ]
Meng, Hai-Tao [1 ,2 ,3 ]
Yu, Wen-Juan [1 ,2 ,3 ]
Tong, Hong-Yan [1 ,2 ,3 ]
Ye, Xiu-Jin [1 ,2 ,3 ]
Jin, Jie [1 ,2 ,3 ]
Zhu, Hong-Hu [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Hematol, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Zhejiang Prov Key Lab Hematol Oncol Diag & Treatm, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
IMATINIB; PHASE-2;
D O I
10.1111/bjh.16661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E231 / E234
页数:4
相关论文
共 50 条
  • [1] Towards chemotherapy-free treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia
    Boer, Judith M.
    van der Sluis, Inge M.
    LANCET HAEMATOLOGY, 2023, 10 (01): : E3 - E5
  • [2] A chemotherapy-free regimen for Philadelphia chromosome-positive acute lymphoblastic leukemia: are we there yet?
    Ofran, Yishai
    HAEMATOLOGICA, 2021, 106 (07) : 1781 - 1782
  • [3] An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
    Short, Nicholas J.
    Konopleva, Marina
    Kadia, Tapan
    Kebriaei, Partow
    Daver, Naval
    Huang, Xuelin
    Masarova, Lucia
    Cook, Robin
    Jain, Nitin
    Jabbour, Elias
    Kantarjian, Hagop
    Ravandi, Farhad
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (07) : E229 - E232
  • [4] yInterim Results of a Phase II Study of Dasatinib and Prednisone As an Oral, Chemo-Free Induction and Consolidation Regimen for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Xie, Mixue
    Lu, Ying
    Ouyang, Guifang
    Zhang, Liming
    Hu, Huixian
    Shi, Ting
    Li, Xueying
    Ye, Xiujing
    Jin, Jie
    Zhu, Hong-Hu
    BLOOD, 2021, 138
  • [5] Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia
    Luskin, Marlise R.
    Murakami, Mark A.
    Keating, Julia
    Flamand, Yael
    Winer, Eric S.
    Garcia, Jacqueline S.
    Stahl, Maximilian
    Stone, Richard M.
    Wadleigh, Martha
    Jaeckle, Stella L.
    Hagopian, Ella
    Weinstock, David M.
    Liegel, Jessica
    Mcmasters, Malgorzata
    Wang, Eunice S.
    Stock, Wendy
    Deangelo, Daniel J.
    BLOOD, 2025, 145 (06) : 577 - 589
  • [6] The Emerging Use of Chemotherapy-Free Regimens in Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Sawyers, Jacquelyn D.
    Jammal, Nadya J.
    Short, Nicholas J.
    Kantarjian, Hagop
    Jabbour, Elias J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (02) : 68 - 75
  • [7] Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia can be Treated with Chemotherapy-Free Regimens without Transplant
    Haddad, Fadi G.
    Kantarjian, Hagop
    Senapati, Jayastu
    Jain, Nitin
    Short, Nicholas J.
    Jabbour, Elias
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S79 - S82
  • [8] A Chemotherapy-Free Induction Followed by Allogeneic HSCT for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Leonard, Jessica T.
    Allen, Bryon
    Slater, Susan
    Maziarz, Richard T.
    Hayes-Lattin, Brandon
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S287 - S288
  • [9] Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Cerchione, Claudio
    Locatelli, Franco
    Martinelli, Giovanni
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Dasatinib A Review of its Use in the Treatment of Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
    McCormack, Paul L.
    Keam, Susan J.
    DRUGS, 2011, 71 (13) : 1771 - 1795